New TB regime cuts down both pills and cost

A new TB regime will lower the number of pills a patient has to take from nine a week to three, which is expected to increase adherence to treatment. — AFP

A new tuberculosis (TB) treatment that slashes costs and the pill burden for patients will be rolled out in five high-incidence countries this year (2021), international medical research body Aurum Institute said on Feb 3.

TB – a respiratory disease that is preventable and treatable, yet kills more than 1.4 million people every year – is chronically underfunded, with diagnosis and treatment failing to reach millions.

It is currently the world’s deadliest infectious disease, with progress to stop its spread unwound by the Covid-19 pandemic as restricted movement measures have disrupted treatment.

“Enough treatments for up to three million patients are expected to be made available for eligible countries this year,” the institute said in a statement.

The new two-drug regime will reduce the weekly pill intake for patients from nine to three.

This is expected to enable better adherence and outcomes, World Health Organization (WHO) global TB programme director Dr Tereza Kasaeva said.

Treatment will initially be administered in Ethiopia, Ghana, Kenya, Mozambique and Zimbabwe.

Seven other nations will follow later.

A deal cut between the manufacturer Macleods, Unitaid and the Clinton Health Access Initiative (CHAI) will cap the price at US$15 (RM60.81) for a complete three-month regime.

Aurum Institute’s chief executive officer Gavin Churchyard said the new treatment regime, coupled with the price reduction, would hopefully help get their aim of eradicating TB by 2030 back on track.

“We lose in the end if Covid-19 mortality goes down, but TB rates go up,” he warned. – AFP Relaxnews

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Tuberculosis , TB , infectious diseases , drugs


Next In Health

Suffering from runner’s knee? This is what's happening
This new drug proves effective for heart failure
When you use your headphones for too long
Religious leaders can lead the way in promoting healthy behaviours Premium
A new antibiotic for hard-to-treat gram-negative infections
Making Malaysia a tobacco-free nation
Tips on managing menopause symptoms
Men more likely to spread Covid-19 than women
When machismo prevents men from seeking mental health help
Clean your house and burn some calories at the same time

Stories You'll Enjoy